Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

As shown in Figure 5H, Firmicutes is the dominant gut microbiota, positively correlated with vitamin D and its derivatives, fatty acylglycosides, fatty acids, and their complexes.

Source: Integrated Analysis of Transcriptomics‐Metabolomics and Gut Microbiota‐ Metabolomics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Eight mice were selected to be fed on a normal diet (ND) (Beijing Keao Xieli Feed Co.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

3′‐Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut‐Immune‐Cardiovascular Axis in LDLR −/− Mice

Study design awaiting verification · Food Science & Nutrition · 2026

Original publication title

3′‐Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut‐Immune‐Cardiovascular Axis in LDLR −/− Mice

Yingying Zhuang; Wei Zhang; Linlin Zhou; Hui Shu; Wenqing Bo; Yiding Wang; Xinyuan Huang; Xinning Zhao; Hanying Zheng; Dongbei Guo; Xiaoxuan Chen; Lili Pan; Hongwei Li; Xinyue Wang

© 2026 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

3′‐sialyllactose (3′‐SL) has demonstrated potential in regulating glycolipid metabolism and improving intestinal immunity, thereby exhibiting anti‐atherosclerotic (AS) properties. However, the mechanism by which 3′‐SL exerts its anti‐AS effects through the regulation of inflammatory signaling via intestinal immunity remains unknown. Herein, 40 male low‐density lipoprotein receptor knockout (LDLR −/−) mice were randomized into five groups: normal diet (ND), high‐cholesterol diet (HCD), and three 3′‐SL groups (low dose SLL, medium dose SLM, high dose SLH). After 12 weeks, atherosclerotic plaque formation, serum lipids including total cholesterol (TC), triglycerides (TG), low‐density lipoprotein (LDL), high‐density lipoprotein (HDL), and inflammatory cytokines including interleukin‐6 (IL‐6), interleukin‐1β (IL‐1β), interleukin‐10 (IL‐10) were measured.

Multi‐omics analyses (gut microbiota 16S sequencing, colonic transcriptomics, and metabolomics) were performed. Compared with the HCD group, 3′‐SL L intervention dose‐dependently and significantly reduced aortic lipid deposition in LDLR −/− mice, lowered serum TG and LDL levels, increased HDL, while markedly decreasing pro‐inflammatory cytokines IL‐6 and IL‐1β and elevating the anti‐inflammatory cytokine IL‐10. Using the SLM group as representative for mechanistic exploration, it was found that 3′‐SL reshaped the gut microbiota structure, significantly increasing the abundance of beneficial Akkermansia and reducing the Firmicutes/Bacteroidetes ratio, thereby restoring microbial balance.

Integrated multi‐omics analysis further revealed that 3′‐SL drove colonic transcriptomic‐metabolic reprogramming, with enriched key pathways mainly involving immune regulation (e.g., Ccl2, Il2ra) and lipid metabolism (e.g., Kng1, C6). Differential metabolites showed significant correlations with immune‐ and cardiovascular‐related genes. Among these, Ccl2 (MCP‐1), as a key molecule linking gut immune signals to coronary artery pathology, was suppressed in expression, which may directly reduce the recruitment of monocytes/macrophages into the subendothelial space, thereby inhibiting the initiation of atherosclerosis. Collectively, 3′‐SL exhibits significant preventive effects against chronic inflammation in LDLR −/− mice with HCD‐induced atherosclerosis.

These effects are mediated through synergistic regulation of metabolic, inflammatory, and microbial pathways along the gut microbiota‐immune‐cardiovascular axis. This axis integrates gut microbial metabolism, immune responses, and transcriptional signaling changes, revealing novel targets for the prebiotic 3′‐SL in preventing atherosclerosis. It provides robust preclinical evidence for nutritional intervention strategies targeting the gut microbiota.

Authors’ abstract

ABSTRACT

3′‐sialyllactose (3′‐SL) has demonstrated potential in regulating glycolipid metabolism and improving intestinal immunity, thereby exhibiting anti‐atherosclerotic (AS) properties. However, the mechanism by which 3′‐SL exerts its anti‐AS effects through the regulation of inflammatory signaling via intestinal immunity remains unknown. Herein, 40 male low‐density lipoprotein receptor knockout (LDLR −/−) mice were randomized into five groups: normal diet (ND), high‐cholesterol diet (HCD), and three 3′‐SL groups (low dose SLL, medium dose SLM, high dose SLH). After 12 weeks, atherosclerotic plaque formation, serum lipids including total cholesterol (TC), triglycerides (TG), low‐density lipoprotein (LDL), high‐density lipoprotein (HDL), and inflammatory cytokines including interleukin‐6 (IL‐6), interleukin‐1β (IL‐1β), interleukin‐10 (IL‐10) were measured.

Multi‐omics analyses (gut microbiota 16S sequencing, colonic transcriptomics, and metabolomics) were performed. Compared with the HCD group, 3′‐SL L intervention dose‐dependently and significantly reduced aortic lipid deposition in LDLR −/− mice, lowered serum TG and LDL levels, increased HDL, while markedly decreasing pro‐inflammatory cytokines IL‐6 and IL‐1β and elevating the anti‐inflammatory cytokine IL‐10. Using the SLM group as representative for mechanistic exploration, it was found that 3′‐SL reshaped the gut microbiota structure, significantly increasing the abundance of beneficial Akkermansia and reducing the Firmicutes/Bacteroidetes ratio, thereby restoring microbial balance.

Integrated multi‐omics analysis further revealed that 3′‐SL drove colonic transcriptomic‐metabolic reprogramming, with enriched key pathways mainly involving immune regulation (e.g., Ccl2, Il2ra) and lipid metabolism (e.g., Kng1, C6). Differential metabolites showed significant correlations with immune‐ and cardiovascular‐related genes. Among these, Ccl2 (MCP‐1), as a key molecule linking gut immune signals to coronary artery pathology, was suppressed in expression, which may directly reduce the recruitment of monocytes/macrophages into the subendothelial space, thereby inhibiting the initiation of atherosclerosis. Collectively, 3′‐SL exhibits significant preventive effects against chronic inflammation in LDLR −/− mice with HCD‐induced atherosclerosis.

These effects are mediated through synergistic regulation of metabolic, inflammatory, and microbial pathways along the gut microbiota‐immune‐cardiovascular axis. This axis integrates gut microbial metabolism, immune responses, and transcriptional signaling changes, revealing novel targets for the prebiotic 3′‐SL in preventing atherosclerosis. It provides robust preclinical evidence for nutritional intervention strategies targeting the gut microbiota.

Publication and source details

Original title: 3′‐Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut‐Immune‐Cardiovascular Axis in LDLR −/− Mice

Yingying Zhuang; Wei Zhang; Linlin Zhou; Hui Shu; Wenqing Bo; Yiding Wang; Xinyuan Huang; Xinning Zhao; Hanying Zheng; Dongbei Guo; Xiaoxuan Chen; Lili Pan; Hongwei Li; Xinyue Wang

Food Science & Nutrition · 2026

* Correspondence:
Hongwei Li (rocque@xmu.edu.cn)
Xinyue Wang (wang.xinyue@zsxmhospital.com)
© 2026 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. 2024 Xiamen Municipal Guiding Project on Medical and Health Care 3502Z20244ZD1104 2025 Xiamen Municipal Guiding Project on Medical and Health Care 3502Z20254ZD1199 Fujian Provincial Natural Science Foundation of China 2025J011505

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:12:18.655340+00:00

DOI: 10.1002/fsn3.72053 · PMC13320821